New cancer clinical trial: Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer

Published on: April 27, 2018 at 12:00PM
Conditions:   Prostate Cancer;   Stage IV Prostate Cancer;   Advanced Prostate Cancer;   Adenocarcinoma of the Prostate
Interventions:   Drug: Adaptive Androgen Deprivation Therapy (ADT);   Drug: Abiraterone;   Drug: Prednisone
Sponsor:   H. Lee Moffitt Cancer Center and Research Institute
Not yet recruiting
https://ift.tt/2vVmCuT